Related Experiment Video
Updated: Aug 26, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
Circulating alpha-actin protein in acute myocardial infarction
A E Aránega1, A Reina, M A Muros
1Department of Morphological Sciences, School of Medicine, University of Granada, Spain.
Insights
Cardiac alpha-actin, a contractile protein, is present in the bloodstream of most acute myocardial infarction patients. This biomarker aids in understanding heart attacks and their associated factors.
Area of Science:
- Biochemistry
- Cardiology
- Molecular Biology
Background:
- Acute myocardial infarction (AMI) diagnosis relies on clinical, ECG, and enzyme markers.
- The presence and significance of circulating contractile proteins in AMI require further investigation.
Purpose of the Study:
- To investigate the presence of cardiac alpha-actin in the blood of AMI patients.
- To determine the diagnostic utility of circulating alpha-actin in AMI.
Main Methods:
- Western-blot analysis using a monoclonal antibody specific for cardiac alpha-actin.
- Analysis of blood samples from 70 AMI patients, 70 healthy controls, and 30 patients with skeletal muscle damage.
Main Results:
- Circulating alpha-actin was detected in 95% of AMI patients (67/70) as a 43 kDa band.
- Alpha-actin was largely absent in healthy controls (98% negative) and patients with skeletal muscle damage.
- Highest concentrations were observed in anterior AMI; detection occurred 1-180 hours post-onset with a biphasic pattern.
Conclusions:
- Circulating cardiac alpha-actin is a sensitive biomarker for acute myocardial infarction.
- Serum alpha-actin levels correlate with AMI subtype, sex, tobacco use, and complications.
- This protein offers potential for deeper understanding of AMI pathophysiology and clinical management.
Abstract:
We used Western-blot analysis to investigate the possible presence in the bloodstream of the contractile protein alpha-actin in 70 patients diagnosed with acute myocardial infarction on the basis of clinical, electrocardiographic and laboratory (creatine kinase and lactate dehydrogenase) criteria. Circulating protein was identified with a monoclonal antibody specific for cardiac alpha-actin. Of the 70 control samples of blood, the immunoblot results were negative for alpha-actin in 98% of the cases. Of the 30 patients with skeletal muscle damage caused by surgery, 26 were negative for circulating alpha-actin. Of the 70 patients with acute myocardial infarction, circulating alpha-actin was found in 67 (95%) as a 43 kDa band in immunoblots; the highest circulating concentrations (0.0580 micrograms/microliters) were found in those with anterior acute myocardial infarction. Circulating alpha-actin was detected in samples taken between 1 and 180 h after the onset of pain, and showed a biphasic pattern of appearance. Our findings for serum alpha-actin, together with the relationship between serum concentrations of this protein and sex (p = 0.001), tobacco use (p = 0.007) and postepisode complications (p = 0.002), should make it possible to gain a deeper understanding of acute myocardial infarction as a clinical entity.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

